HTL0039732 in Participants With Advanced Solid Tumours

NCT05944237 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Neoplasms
Prostatic Neoplasms, Castration-Resistant
Stomach Neoplasms
Esophageal Neoplasms
Head and Neck Neoplasms
Colorectal Neoplasms
Pancreatic Neoplasms
Lung Neoplasms
Urinary Bladder Neoplasms
Mesothelioma, Malignant
Uterine Cervical Neoplasms
Kidney Neoplasms
Sarcoma
Pheochromocytomas

Interventions

DRUG: HTL0039732 Capsules
DRUG: HTL0039732 Capsules and atezolizumab infusion

Sponsor

Cancer Research UK

Collaborators

[object Object]